AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,322,649 | +10.8% | 2,098,993 | +5.0% | 5.76% | +15.4% |
| Q3 2022 | $13,833,000 | +6.0% | 1,998,993 | +7.1% | 4.99% | +12.0% |
| Q2 2022 | $13,048,000 | -3.8% | 1,866,652 | +13.8% | 4.45% | +123.4% |
| Q1 2022 | $13,563,000 | -23.4% | 1,640,000 | 0.0% | 1.99% | -0.8% |
| Q4 2021 | $17,712,000 | +5.8% | 1,640,000 | +18.0% | 2.01% | -33.9% |
| Q3 2021 | $16,743,000 | +21.1% | 1,390,000 | +21.9% | 3.04% | -15.4% |
| Q2 2021 | $13,828,000 | +24.1% | 1,140,000 | +42.5% | 3.59% | +78.4% |
| Q1 2021 | $11,144,000 | -1.6% | 800,000 | 0.0% | 2.01% | -14.4% |
| Q4 2020 | $11,328,000 | – | 800,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $64,658,056 | 27.18% |
| Stonepine Capital Management, LLC | 6,333,239 | $46,232,645 | 19.45% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $19,482,554 | 8.15% |
| Aquilo Capital Management, LLC | 2,098,993 | $15,322,649 | 5.76% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,283,080 | 2.38% |
| Global Frontier Investments LLC | 505,000 | $3,687 | 1.62% |
| Telemetry Investments, L.L.C. | 130,262 | $951 | 1.50% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $46,235 | 1.27% |
| Rubric Capital Management LP | 3,600,000 | $26,280,000 | 1.15% |
| Clearline Capital LP | 631,942 | $4,613,176 | 0.82% |